Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder

Posted On: 2021-03-05 00:51:33 (Time Zone: Arizona, USA)


Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced a new brand ambassador for its global consumer care business. Mr. Rohit Sharma, also known as the 'Hitman of Indian Cricket' has officially signed on to represent Glenmark's Candid Powder, a legacy brand of the company's consumer care division. Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.

Skin problems are increasingly common today, resulting from hot and humid climate conditions. Glenmark's Candid Dusting Powder is an expert skin solution to four key skin problems: redness, irritation, sweat rash and fungal infections.

Over the years, Candid powder has gained the trust of doctors and become the largest prescribed brand in its category (IQVIA Medical Audit, Jan 20) Commenting on the association, Mr. Dhawal Katkar, Vice President and Head - Glenmark Consumer Care at Glenmark Pharmaceuticals, said, "We are excited to be associated with Rohit Sharma. He brings refined expertise and skill to the game of cricket in much the same way that Candid Powder has proven to be an expert in the solution of 4 skin problems. Just like Rohit Sharma has all-round expertise in all formats of the game, Candid Powder too, is a proven solution for identified skin related problems."

Rohit Sharma is one of the greatest batsmen of the modern era. Having registered several batting records and bringing many laurels for the country, Rohit was recently bestowed with the Rajiv Gandhi Khel Ratna Award, the highest sports honour in the country. A respected and adored name in India and globally, Rohit Sharma has been a consistent performer - both as a player and leader. Rohit, who is handled exclusively by RISE Worldwide, has also led Mumbai Indians to a record 5 IPL titles.

Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.474 as compared to the previous close of Rs. 479. The total number of shares traded during the day was 101055 in over 2432 trades.

The stock hit an intraday high of Rs. 478.6 and intraday low of 470.1. The net turnover during the day was Rs. 47950605.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Subex to launch new AI Automation Platform on April 22, 2021

Easy Trip Planners Ltd board declares interim dividend of Rs. 2

Firstsource Solutions Ltd board to consider Q4, FY21 results on May 11, 2021

Happiest Minds wins Times Ascent - World HRD Congress HR Excellence Awards 2021

Indian Energy Exchange commences Cross Border Electricity Trade through its platform

Caplin Steriles gets USFDA approval for Milrinone Lactate Injection

NTPC Ltd declares commercial operation of 85 MW Bilhaur Solar PV Project

G E Shipping takes delivery of a Secondhand Midsize Gas Carrier 'Jag Vikram'

Copenhagen Fintech welcomes Infosys to Elevate Fintech Innovation

Ambuja 'Kawach' recognized globally by Solar Impulse Foundation's efficient solution label

India Ratings assigns Sobha 'IND AA-'/Stable

Sarda Energy & Minerals Ltd updates on Madhya Bharat Power Corporation Ltd

Can Fin Homes Ltd board to consider dividend, Q4, FY21 results on April 30, 2021

HCL to drive end-to-end IT transformation at UD Trucks

WeP Solutions Ltd rights issue to close today

IFGL Refractories Ltd board to consider FY21 results, dividend on May 22, 2021

United Breweries Ltd board to recommend dividend, consider Q4, FY21 results on April 27, 2021

Goa Carbon Limited temporarily shuts down Goa unit for maintenance from April 17, 2021

Sonata Software Ltd board to approve Q4, FY2021 results on May 12, 2021

KPIT Technologies Ltd board to consider dividend, Q4, FY21 results on April 28, 2021

Macrotech Developers Ltd to list on April 19, 2021

KSB Ltd board to approve Q1CY21 results on April 28, 2021

INOX Leisure Limited Ratings downgraded to 'CRISIL A+/Negative/CRISIL A1'

Bhansali Engineering Polymers Ltd Board approves dividend of Rs. 1 for FY21

All Wonderla Amusement Parks will open only on Friday, Saurday and Sunday from April 19, 2021

Bhansali Engineering Polymers Ltd Q4FY21 consolidated PAT jumps to Rs. 163.48 crore

Kalyan Jewellers ushers in the wedding season with its latest Muhurat Campaign

IndusInd Bank Ltd board to consider Q4, FY21 results on April 30, 2021

Jubilant Ingrevia Ltd appoints two directors to its board

Wockhardt Ltd board to consider raising funds through NCDs on April 21, 2021

Trident Ltd celebrating Mission Day with a special discount coupon to shareholders

S.P. Capital Financing Ltd approves selling of shares in Pride And Expert Properties Private Limited

IIFL Securities Limited to acquire Category II AIF from IIFL Wealth Management Ltd

HDFC Bank Limited to raise up to Rs. 50,000 crore

Indo Asian Finance Ltd to consider allotment of 60 lakh shares on April 20, 2021

KEC International Limited Resumption of WKTL Transmission Project

IIFL Wealth Management Ltd to sell AIF Category-II business to IIFL Management Services Ltd

International Travel House Ltd Q4FY21 loss at Rs. 6.70 crore

Gujarat Hotels Ltd Q4FY21 net profit slides YoY, QoQ

ICICI Lombard General Insurance Company Limited board recommends final dividend of Rs. 4

Gujarat Hotels Ltd board recommends dividend of Rs. 1.80 for FY21

ICICI Lombard General Insurance Company Ltd reports Rs. 345.68 crore PAT in Q4FY21

HDFC Bank Ltd's gross NPAs at 1.32%, reduces QoQ

HDB Financial Services Ltd's gross NPAs at 3.9% as of March 31, 2021

HDFC Securities Ltd reports PAT of Rs. 253.1 crore in Q4FY21

Career Point signed MOU with Ministry of Social Justice and Empowerment for tutorial services

HDFC Bank's balance sheet increases 14.1% YoY

Indiamart arm to acquire 22% in Truckhall Pvt Ltd

HDFC Bank Ltd Q4FY21 consolidated net profit slips QoQ to Rs. 8433.78 crore

CRISIL downgrades rating of PVR Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020